Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06489873 · ClinicalTrials.gov registry record · NA
Lutein, Zeaxathin, and Fish Oil Supplementation
A NA study of Age-related Macular Degeneration and Bone Loss, sponsored by Texas A&M University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06489873 is a NA study of Age-related Macular Degeneration and Bone Loss that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 80 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06489873, a NA study of Age-related Macular Degeneration and Bone Loss, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo Comparator
- DIETARY_SUPPLEMENT Active Comparator (Lutein, zeaxanthin, and fish oil supplement (LZF)
Study Locations (1)
Texas
- Gilchrist Building - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06489873
The ClinicalTrials.gov registry entry for NCT06489873 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (95% lower). The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT06489873 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06489873 about?
NCT06489873 is a clinical study titled "Lutein, Zeaxathin, and Fish Oil Supplementation". The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to c...
What is the current status of trial NCT06489873?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-02-07. Estimated completion is 2026-05-01.
What conditions does trial NCT06489873 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Bone Loss, Cognitive Performance.
What interventions are being tested in trial NCT06489873?
The interventions under investigation include: Placebo Comparator (DIETARY_SUPPLEMENT), Active Comparator (Lutein, zeaxanthin, and fish oil supplement (LZF) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06489873?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06489873 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
RECRUITING · NA
-
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.